Unraveling the differential diagnosis of hyperferritinemia: insights from a retrospective study at a tertiary care hospital
Postgraduate Medical Journal · 22.06.2025 · 101 (1197) · 612-619
DOI: 10.1093/postmj/qgae194 ↗Kurz gefasst
Fachartikel in der Zeitschrift Postgraduate Medical Journal, online erschienen am 06.01.2025. Verfasst von Lucy Eunju Lee und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Republic…. Hauptthemen laut MEDLINE: Hyperferritinemia, Ferritins, Fever, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben.
Abstract (Originalsprache)
Objectives
Elevated serum ferritin levels are associated with various clinical conditions, including inflammation and tissue damage. This study aims to investigate the distribution of diagnoses associated with hyperferritinemia in different clinical contexts.
Methods
Patients admitted to Severance Hospital, Seoul, Korea, between January and December 2017, with serum ferritin levels of 500 ng/ml or higher, were included. A retrospective chart review was conducted to collect demographic information, underlying diseases, ferritin levels, and febrile status. Patients were categorized by age (≥20 vs. <20 years), febrile status (febrile vs. afebrile), and ferritin cut-off levels (≥500, ≥1000, ≥2000, ≥3000, and ≥ 10 000 ng/ml). Diagnoses were classified into 10 categories, and their distribution was analyzed across patient subgroups with different characteristics.
Results
Among 2044 patients with hyperferritinemia, solid organ malignancies (37.1%) were the most common cause, followed by infections (23.4%) and hematologic disorders (14.9%). Younger patients had higher ferritin levels and a greater prevalence of hematologic (38.8% vs. 12.9%) and rheumatic diseases (6.6% vs. 3.7%). Febrile patients exhibited higher ferritin levels and more frequent diagnoses of infections (27.2% vs. 12.5%), hematologic (16.2% vs. 11.2%), and rheumatic diseases (4.7% vs. 1.5%). As ferritin levels increased, hematologic and rheumatic diseases became more prevalent, although other diagnoses remained common across ferritin levels.
Conclusion
Hyperferritinemia has a broad range of underlying causes, with diagnostic distributions varying by age, febrile status, and ferritin levels. These findings underscore the importance of comprehensive evaluation and contextual interpretation for patients with unexplained hyperferritinemia, advocating for a tailored diagnostic approach based on clinical context.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Republic of Korea.
- Division of Rheumatology, Department of Internal Medicine, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul 06591, Republic of Korea.
ORCID-Profile: Seung Min Jung
Zitieren
APA
Lee, L. E., Lee, S. W., Song, J. J., Park, Y. B., & Jung, S. M. (2025). Unraveling the differential diagnosis of hyperferritinemia: insights from a retrospective study at a tertiary care hospital. Postgraduate Medical Journal, 101(1197), 612-619. https://doi.org/10.1093/postmj/qgae194
Vancouver
Lee LE, Lee SW, Song JJ, Park YB, Jung SM. Unraveling the differential diagnosis of hyperferritinemia: insights from a retrospective study at a tertiary care hospital. Postgraduate Medical Journal. 2025;101(1197):612-619. doi:10.1093/postmj/qgae194
BibTeX
@article{Lee2025,
author = {Lee, Lucy Eunju and Lee, Sang-Won and Song, Jason Jungsik and Park, Yong-Beom and Jung, Seung Min},
title = {Unraveling the differential diagnosis of hyperferritinemia: insights from a retrospective study at a tertiary care hospital},
journal = {Postgraduate Medical Journal},
year = {2025},
volume = {101},
number = {1197},
pages = {612--619},
doi = {10.1093/postmj/qgae194}
}
EUVIMED